Morgan Stanley Idexx Laboratories Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Morgan Stanley holds 1,663,326 shares of IDXX stock, worth $1.06 Billion. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,663,326

Previous 1,658,345 0.3%

Holding current value

$1.06 Billion

Previous $696 Million 28.1%

% of portfolio

0.06%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$361.04 - $536.34 $1.8 Million - $2.67 Million	4,981 Added 0.3%	1,663,326 $892 Million
Q1 2025 May 15, 2025	BUY	$406.29 - $469.04 $10.3 Million - $11.9 Million	25,306 Added 1.55%	1,658,345 $696 Million
Q4 2024 Feb 14, 2025	BUY	$406.92 - $495.42 $184 Million - $224 Million	451,330 Added 38.19%	1,633,039 $675 Million
Q3 2024 May 14, 2025	BUY	$455.08 - $517.19 $18.5 Million - $21.1 Million	40,749 Added 3.57%	1,181,709 $597 Million
Q3 2024 Nov 14, 2024	BUY	$455.08 - $517.19 $18.5 Million - $21.1 Million	40,749 Added 3.57%	1,181,709 $597 Million
Q2 2024 May 14, 2025	SELL	$468.04 - $548.53 $230 Million - $270 Million	-492,079 Reduced 30.13%	1,140,960 $556 Million
Q2 2024 Oct 17, 2024	SELL	$468.04 - $548.53 $39.8 Million - $46.6 Million	-84,970 Reduced 6.93%	1,140,960 $556 Million
Q2 2024 Aug 14, 2024	SELL	$468.04 - $548.53 $39.8 Million - $46.6 Million	-84,970 Reduced 6.93%	1,140,960 $556 Million
Q1 2024 Oct 17, 2024	BUY	$515.08 - $576.87 $43.8 Million - $49 Million	84,970 Added 7.45%	1,225,930 $662 Million
Q1 2024 Aug 16, 2024	BUY	$515.08 - $576.87 $67.4 Million - $75.5 Million	130,950 Added 11.96%	1,225,930 $662 Million
Q1 2024 May 15, 2024	BUY	$515.08 - $576.87 $67.4 Million - $75.5 Million	130,950 Added 11.96%	1,225,930 $662 Million
Q4 2023 Aug 16, 2024	SELL	$391.37 - $557.56 $18 Million - $25.6 Million	-45,980 Reduced 4.03%	1,094,980 $608 Million
Q4 2023 Feb 13, 2024	BUY	$391.37 - $557.56 $11.9 Million - $17 Million	30,466 Added 2.86%	1,094,980 $608 Million
Q3 2023 Nov 15, 2023	BUY	$432.42 - $556.67 $20.8 Million - $26.8 Million	48,095 Added 4.73%	1,064,514 $465 Million
Q2 2023 Aug 14, 2023	BUY	$450.7 - $503.61 $36.4 Million - $40.7 Million	80,720 Added 8.63%	1,016,419 $510 Million
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $20.5 Million - $26 Million	-50,533 Reduced 5.12%	935,699 $468 Million
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $84.7 Million - $115 Million	260,926 Added 35.97%	986,232 $402 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $9.88 Million - $12.4 Million	-30,313 Reduced 4.01%	725,306 $236 Million
Q2 2022 Oct 27, 2022	BUY	$327.37 - $553.44 $145 Million - $246 Million	443,914 Added 142.41%	755,619 $265 Million
Q2 2022 Aug 15, 2022	BUY	$327.37 - $553.44 $145 Million - $246 Million	443,914 Added 142.41%	755,619 $265 Million
Q1 2022 Oct 27, 2022	SELL	$466.52 - $631.01 $207 Million - $280 Million	-443,914 Reduced 58.75%	311,705 $171 Million
Q1 2022 May 13, 2022	SELL	$466.52 - $631.01 $59.2 Million - $80.1 Million	-126,994 Reduced 28.95%	311,705 $171 Million
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $45 Million - $51.1 Million	76,726 Added 21.2%	438,699 $289 Million
Q3 2021 Nov 15, 2021	BUY	$621.9 - $705.76 $225 Million - $255 Million	361,973 New	361,973 $225 Million

Others Institutions Holding IDXX

# of Institutions

1,391

Shares Held

75.4M

Call Options Held

177K

Put Options Held

226K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $53B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account